“Trends and challenges in adverse drug reaction reporting in Spain: Analysis of the FEDRA database (2019–2023)”
- 20 December 2025
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 82 (1) , 8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industryEuropean Journal of Clinical Pharmacology, 2020
- EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health ProtectionDrug Safety, 2018
- Pharmacovigilance in Spain2014
- Performance of Probabilistic Method to Detect Duplicate Individual Case Safety ReportsDrug Safety, 2014
- Quantitative signal detection using spontaneous ADR reportingPharmacoepidemiology and Drug Safety, 2009
- A statistical methodology for drug–drug interaction surveillanceStatistics in Medicine, 2008
- Duplicate detection in adverse drug reaction surveillanceData Mining and Knowledge Discovery, 2007
- On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under‐reporting on odds ratiosStatistics in Medicine, 2002